Europe Glucose Monitoring Devices Market

The Europe glucose monitoring devices market is expected to grow from US$ 5,248.87 million in 2022 to US$ 12,118.27 million by 2030. It is estimated to grow at a CAGR of 11.0% from 2022 to 2030.

Growing Medical Tourism in Developing Countries Fuel Europe Glucose Monitoring Devices Market

The emerging markets in developing countries are the major factor that gives the major players a better opportunity to expand their business. These are a major reason for the market growth during the forecast period. Most market players focus on emerging markets due to the prevalence of diabetes and the increasing popularity of glucose monitoring devices in the region. In India, medical science has progressed rapidly over the past few decades. Several international patients visit India in the pursuit of incredibly affordable medical care. Moreover, Poland has slowly become a favourite medical tourism destination in Europe. For instance, in Poland, medical treatment costs are often lower by 60–80% compared to the same benefits in the rest of the EU countries. The major reason for the growth of tourism is Poland's recognition and acceptance of the European Union. The rising medical tourism in emerging nations such as Poland is anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.

Europe Glucose Monitoring Devices Market Overview

The Europe glucose monitoring devices market has been segmented into the Germany, France, UK, Italy, Spain, Rest of Europe. The market growth in this region is attributed to the rising awareness of the diabetes diagnosis, increasing ageing population, and technological advancements in glucose monitoring thereby dominating the overall market growth.

Europe Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

Europe Glucose Monitoring Devices Market Segmentation

The Europe glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the Europe glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on application, the Europe glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on testing site, the Europe glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on end user, the Europe glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on country, the Europe glucose monitoring devices market is segmented into the Germany, UK, France, Italy, Spain, and Rest of Europe. Germany dominated the Europe glucose monitoring devices market in 2022.   

B. Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Senseonics Holdings Inc, Nipro Corp, GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the Europe glucose monitoring devices market.    

Europe Glucose Monitoring Devices Market Strategic Insights

Europe Glucose Monitoring Devices Market Segmentation Analysis

Europe Glucose Monitoring Devices Market Report Highlights

Europe Glucose Monitoring Devices Report Scope

Europe Glucose Monitoring Devices Market Country and Regional Insights